Citi upgraded Medtronic (MDT) to Buy from Neutral with a price target of $107, up from $92.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- Haemonetics announces updates to its Executive Leadership team
- Medtronic call volume above normal and directionally bullish
- Optimistic Buy Rating for Medtronic Driven by Renal Denervation’s Market Potential and Endorsements
- Medtronic’s BrainSense brain stimulation system approved by FDA for Parkinson’s
- Amgen (NASDAQ:AMGN) to Invest $200M in India High Tech Site as Trump Tariffs Loom